Tech Support

TECHNICAL SUPPORT
+1.800.674.3430

This line is for technical support.
For General Enquiries please click General Contact

SYMPOSIUM: Cellular Therapies in Oncology and Beyond: from Drug Development to Clinical Applications

June 27th, 2019: 08:00 - 17:00
Janssen Research Campus, Beerse, Belgium

Crown/JnJ symposium

Crown Bioscience and Janssen Pharmaceutica cordially invite you to our second jointly organized symposium, this year discussing Cellular Therapies in Oncology and Beyond: from Drug Development to Clinical Applications on June 27th.

Internationally renowned speakers from academia and industry will discuss the latest developments in cellular therapies, and how these are being applied from the early stages of drug discovery through to improving patient clinical response.

Speakers

Dr. Reagan Jarvis
Dr. Reagan Jarvis

CEO and Co-founder
Anocca AB
Standardisation of Cell-Based Assays for T Cell Immunity: Towards Highly Segmented and Individualised TCR-T Therapies

Dr. David Gilham
Dr. David Gilham

Vice President Research and Development
Celyad
Exploiting the Innate Immune for Autologous and Allogeneic CAR T Cell Therapy   

   
Dr. Miguel Forte
Dr. Miguel Forte

CEO
Zelluna Immunotherapy
Opportunities and Challenges in Cellular Immuno-Oncology: HLA Class II TCR for Solid Cancer

Prof. Dr. Frank Buchholz
Prof. Dr. Frank Buchholz

Professor for Medical Systems Biology, Head of Translational Research
University Cancer Center, TU Dresden
Programmable Nucleases and Designer Recombinases for Genome Surgery

   
Dr. Hinrich Abken
Prof. Dr. Hinrich Abken

Professor and Chair for Genetic Immunotherapy
RCI, Regensburg Center for Interventional Immunology
CAR, TRUCKs and Beyond: New Generations of Redirected T Cells

Dr. Nehal Solanki Patel
Dr. Nehal Solanki Patel

Sr. Scientist, CAR T Group
Janssen Research and Development
The T Cell Revolution

   
Dr. Stefanos Theoharis
Dr. Stefanos Theoharis

SVP Corporate Development and Partnering
Cell Medica
Advantages of NKT cells for Autologous and Off-the-Shelf CAR Therapeutics

Dr. Rajendra Kumari
Dr. Rajendra Kumari

Global Head of Scientific Communications
Crown Bioscience
How to Detect, Quantify and Characterise CAR-T in Treated Patients

   
Dr. Margit Jeschke
Dr. Margit Jeschke

Global Head, Analytical Stewardship and CMC Correlational Sciences
Novartis
TBA

Dr. Michael Leek
Dr. Michael Leek

Chief Executive
TC BioPharm Limited
Allogeneic Gamma-Delta T Cells, a Therapeutic Platform for CAR-T Therapies


Moderators

Dr. Janine Arts
Dr. Janine Arts

Sr Director, Scientific Innovation
Oncology, Janssen R&D

Dr. Ulrike Philippar
Dr. Ulrike Philippar

Scientific Director
Oncology, Janssen R&D


jannsen jannsen The symposium will be held on the Janssen research campus in Beerse, Belgium on June 27th, 2019. Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.

In addition to the scientific sessions, there will be ample opportunities to network during coffee breaks, the provided conference lunch and closing reception

Register Now!

Register Now

Your privacy is important to us.
We'll never share your information.

SHARE THIS